Pad Chivukula, Chief Scientific Officer & COO at Arcturus Therapeutics Holdings Inc. (ARCT), sold 17,130 shares at $35.01 ($600K) on 2024-03-19, disclosed to the SEC on 2024-03-21.
Scheduled sale ($600k) by Chief Scientific Officer & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.01 | 8,565 | $300K | 50.0% |
| 2 | $35.01 | 8,565 | $300K | 50.0% |
| Total | $35.01 avg | 17,130 | $600K | 100% |
| Filing → |
| ARCT | SELL | 2024-06-04 | $1.0M | — | Filing → |
| ARCT | SELL | 2024-03-27 | $1.2M | — | Filing → |
| ARCT | SELL | 2023-11-03 | $94K | — | Filing → |